Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Breaking News
WRAL Weather Alert Day issued for Sunday due to Level 2 risk for severe storms
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biora Therapeutics, Inc. - Common Stock
(NQ:
BIOR
)
0.6587
-0.0068 (-1.02%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biora Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 13, 2023
Via
Benzinga
Biora Therapeutics to Report Third Quarter 2023 Financial Results and Provide Corporate Update
November 06, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Submits Updated IND Application for BT-600
October 30, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics to Submit Updated IND Application for BT-600
October 23, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Robot Pills: A Game-Changer In Drug Delivery, With Potential Stock Upside
September 04, 2023
Via
Benzinga
Earnings Scheduled For November 13, 2023
November 13, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.
Via
Benzinga
Earnings Outlook For Biora Therapeutics
November 10, 2023
Via
Benzinga
Biora Therapeutics Presents Data on the BioJet™ Systemic Oral Delivery Platform at the 59th Annual Meeting of the European Association for the Study of Diabetes
October 05, 2023
Autonomous next-gen device exceeded performance targets in three recent preclinical studies
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
HC Wainwright & Co. Maintains Buy Rating for Biora Therapeutics: Here's What You Need To Know
October 02, 2023
Via
Benzinga
Biora Therapeutics Announces Submission of IND Application to the U.S. FDA for BT-600 Program
September 25, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Hidden Gems: 3 Penny Stocks Flying Under the Radar.
September 22, 2023
Overlooked penny stocks are set to rally once the overall stock market and economy pivot to the upside - These are three winners.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Biora Therapeutics Reduces Debt and Largest Shareholder Increases Equity Exposure
September 19, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference
September 11, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Progresses its BioJet™ Systemic Oral Delivery Platform
September 05, 2023
Confirmation of autonomous device function enables progress to testing of pharma collaborators’ molecules
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
August 14, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Announces New Patents Covering its BioJet™ Systemic Oral Delivery Platform
August 03, 2023
Intellectual property relates to key features of the company’s liquid jet injection technology
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics to Participate in Canaccord Genuity 43rd Annual Growth Conference
August 02, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Announces Clinical Device Performance Study Results for its NaviCap™ Targeted Oral Delivery Platform
July 27, 2023
Phase 1-ready device shows 100% success in human functional study of twelve subjects to date
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics to Report Second Quarter 2023 Financial Results and Provide Corporate Update
July 17, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Continues to Monetize Legacy Diagnostics Assets
July 05, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Announces New Patents for its NaviCap™ Targeted Oral Delivery Platform
June 28, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Presents Data on the BioJet™ Systemic Oral Delivery Platform at the American Diabetes Association 83rd Scientific Sessions
June 26, 2023
An average bioavailability of 37% for a GLP-1 receptor agonist was achieved in animals
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 13, 2023
Via
Benzinga
Why Motorcar Parts of America Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 13, 2023
Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares gained 143% to $2.77 after the company achieved its enrollment target for its adrulipase Phase 2 SPAN trial for exocrine pancreatic...
Via
Benzinga
Dow Surges 100 Points; US Inflation Rate Drops In May
June 13, 2023
U.S. stocks traded higher this morning, with Dow Jones gaining over 100 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.32% to 34,173.85 while the NASDAQ rose 0.72% to...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 13, 2023
Via
Benzinga
Biora Therapeutics Announces $8 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
June 13, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
June 09, 2023
Via
Benzinga
Biora Therapeutics to Present Preclinical Data on the BioJet™ Systemic Oral Delivery Platform at the 59th Annual Meeting of the European Association for the Study of Diabetes
June 08, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 24, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.